Keywords: encouraging, data, mabthera, ra, phase, ii, dancer

Encouraging data for MabThera in RA

Article | 20 June 2005

Print This

Data from the Phase II DANCER (Dose-Ranging Assessment iNternational Clinical Evaluation of Rituximab in RA) study, presented at the European ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in